{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:20:11Z","timestamp":1790803211219,"version":"4.1.0"},"reference-count":70,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T00:00:00Z","timestamp":1623628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Transforming growth factor beta (TGF-\u03b2), as a master regulator of immune response, is deeply implicated in the complex pathophysiology and development of autoimmune thyroid diseases. Based on the close interplay between thyroid autoimmunity and TGF-\u03b2, scientific interest was shifted to the understanding of the possible role of this molecule regarding the diagnosis, prognosis, and therapy of these diseases. The main aim of this review is to present research data about possible treatment options based on the role of TGF-\u03b2 in thyroid autoimmunity. Suggested TGF-\u03b2-mediated therapeutic strategies regarding autoimmune thyroid diseases include either the enhancement of its immunosuppressive role or inhibition of its facilitatory role in thyroid autoimmunity. For example, the application of hr-TGF-\u03b2 can be used to bolster the inhibitory role of TGF-\u03b2 regarding the development of thyroid diseases, whereas anti-TGF-\u03b2 antibodies and similar molecules could impede its immune-promoting effects by blocking different levels of TGF-\u03b2 biosynthesis and activation pathways. In conclusion, TGF-\u03b2 could evolve to a promising, novel therapeutic tool for thyroid autoimmunity.<\/jats:p>","DOI":"10.3390\/medicina57060621","type":"journal-article","created":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T22:25:46Z","timestamp":1623709546000},"page":"621","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["TGF-\u03b2 Physiology as a Novel Therapeutic Target Regarding Autoimmune Thyroid Diseases: Where Do We Stand and What to Expect"],"prefix":"10.3390","volume":"57","author":[{"given":"Efstratios","family":"Kardalas","sequence":"first","affiliation":[{"name":"Endocrine Unit, Aretaieion Hospital, Medical School, National and Kapodistrian University of Athens, Vasilissis Sofias Str. 76, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spyridoula","family":"Maraka","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Arkansas for Medical Sciences, 4301 W. Markham St., Little Rock, AR 72501, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Papagianni","sequence":"additional","affiliation":[{"name":"Unit of Endocrinology, Diabetes and Metabolism, 3rd Department of Pediatrics, Aristotle University School of Health Sciences, Hippokration Hospital of Thessaloniki, Konstantinoupoleos Str. 49, 54642 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4300-7061","authenticated-orcid":false,"given":"George","family":"Paltoglou","sequence":"additional","affiliation":[{"name":"Endocrine Unit, Aretaieion Hospital, Medical School, National and Kapodistrian University of Athens, Vasilissis Sofias Str. 76, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0850-6623","authenticated-orcid":false,"given":"Charalampos","family":"Siristatidis","sequence":"additional","affiliation":[{"name":"Assisted Reproduction Unit, Second Department of Obstetrics and Gynecology, Aretaieion Hospital, Medical School, National and Kapodistrian University of Athens, Vasilissis Sofias Str. 76, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Mastorakos","sequence":"additional","affiliation":[{"name":"Endocrine Unit, Aretaieion Hospital, Medical School, National and Kapodistrian University of Athens, Vasilissis Sofias Str. 76, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,6,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.it.2010.04.002","article-title":"TGF-\u03b2 and immune cells: An important regulatory axis in the tumor microenvironment and progression","volume":"31","author":"Yang","year":"2010","journal-title":"Trends Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/0896-8411(91)90186-G","article-title":"The immunoregulatory influence of transforming growth factor beta in thyroid autoimmunity: TGF \u03b2 inhibits autoreactivity in Graves\u2019 disease","volume":"4","author":"Widder","year":"1991","journal-title":"J. Autoimmun."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/eji.200839105","article-title":"Novel therapeutic targets along the Th17 pathway","volume":"39","author":"Ouyang","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/jcb.25496","article-title":"TGF-\u03b2 Signaling in Cancer","volume":"117","author":"Syed","year":"2016","journal-title":"J. Cell. Biochem."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"a021873","DOI":"10.1101\/cshperspect.a021873","article-title":"TGF-\u03b2 and the TGF-\u03b2 Family: Context-Dependent Roles in Cell and Tissue Physiology","volume":"8","author":"Morikawa","year":"2016","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1042\/CS20110086","article-title":"TGF-\u03b2\/TGF-\u03b2 receptor system and its role in physiological and pathological conditions","volume":"121","author":"Quintanilla","year":"2011","journal-title":"Clin. Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"a022103","DOI":"10.1101\/cshperspect.a022103","article-title":"Structural Biology and Evolution of the TGF-\u03b2 Family","volume":"8","author":"Hinck","year":"2016","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.matbio.2015.05.005","article-title":"Latent TGF-\u03b2-binding proteins","volume":"47","author":"Robertson","year":"2015","journal-title":"Matrix Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.ejcb.2008.01.012","article-title":"Integrins and the activation of latent transforming growth factor \u03b21\u2014An intimate relationship","volume":"87","author":"Wipff","year":"2008","journal-title":"Eur. J. Cell Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0092-8674(00)00121-5","article-title":"TGF\u03b2 Signaling in Growth Control, Cancer, and Heritable Disorders","volume":"103","author":"Blain","year":"2000","journal-title":"Cell"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0092-8674(03)00432-X","article-title":"Mechanisms of TGF-\u03b2 Signaling from Cell Membrane to the Nucleus","volume":"113","author":"Shi","year":"2003","journal-title":"Cell"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.cellsig.2018.09.002","article-title":"TGF-\u03b2 receptors: In and beyond TGF-\u03b2 signaling","volume":"52","author":"Ark","year":"2018","journal-title":"Cell. Signal."},{"key":"ref_13","first-page":"577","article-title":"Smad-dependent and Smad-independent pathways in TGF-\u03b2 family signalling","volume":"425","author":"Derynck","year":"2003","journal-title":"Nat. Cell Biol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Andrieux, G., Fattet, L., Le Borgne, M., Rimokh, R., and Th\u00e9ret, N. (2012). Dynamic Regulation of Tgf-B Signaling by Tif1\u03b3: A Computational Approach. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0033761"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1183\/09031936.06.00078405","article-title":"Altered expression of the Smad signalling pathway: Implications for COPD pathogenesis","volume":"28","author":"Zandvoort","year":"2006","journal-title":"Eur. Respir. J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.trecan.2016.11.008","article-title":"Targeting TGF-\u03b2 Signaling in Cancer","volume":"3","author":"Colak","year":"2017","journal-title":"Trends Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"a022129","DOI":"10.1101\/cshperspect.a022129","article-title":"Non-Smad Signaling Pathways of the TGF-\u03b2 Family","volume":"9","author":"Zhang","year":"2016","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1515\/hsz-2017-0217","article-title":"TGF-\u03b2 requires the activation of canonical and non-canonical signalling pathways to induce skeletal muscle atrophy","volume":"399","author":"Campos","year":"2018","journal-title":"Biol. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"587193","DOI":"10.1155\/2015\/587193","article-title":"TGF\u03b2 Signaling in Tumor Initiation, Epithelial-to-Mesenchymal Transition, and Metastasis","volume":"2015","author":"Papageorgis","year":"2015","journal-title":"J. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/joim.12898","article-title":"Innate immunity\u2014A clinical perspective","volume":"285","author":"Egesten","year":"2019","journal-title":"J. Intern. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/j.jaci.2009.09.017","article-title":"Adaptive immunity","volume":"125","author":"Bonilla","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/bs.ai.2017.01.001","article-title":"Regulation of Innate and Adaptive Immunity by TGF\u03b2","volume":"134","author":"Kelly","year":"2017","journal-title":"Adv. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-immunol-032713-120257","article-title":"TGF-\u03b2 Activation and Function in Immunity","volume":"32","author":"Travis","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.4049\/jimmunol.1301843","article-title":"TGF-\u03b2: Guardian of T Cell Function","volume":"191","author":"Oh","year":"2013","journal-title":"The Journal of Immunology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.immuni.2015.04.005","article-title":"Regulatory B Cells: Origin, Phenotype, and Function","volume":"42","author":"Rosser","year":"2015","journal-title":"Immunity"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.1172\/JCI76179","article-title":"TGF-\u03b2 prevents T follicular helper cell accumulation and B cell autoreactivity","volume":"124","author":"McCarron","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"431718","DOI":"10.4061\/2011\/431718","article-title":"EGF and TGF-1 Effects on Thyroid Function","volume":"2011","author":"Mincione","year":"2011","journal-title":"J. Thyroid Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"875125","DOI":"10.4061\/2011\/875125","article-title":"Role of estrogen in thyroid function and growth regulation","volume":"2011","author":"Santin","year":"2011","journal-title":"J. Thyroid Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.mce.2011.02.001","article-title":"Estradiol modulates TGF-\u03b21 expression and its signaling pathway in thyroid stromal cells","volume":"337","author":"Gantus","year":"2011","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.clim.2018.02.006","article-title":"Estrogen receptor \u03b2 activation stimulates the development of experimental autoimmune thyroiditis through up-regulation of Th17-type responses","volume":"190","author":"Qin","year":"2018","journal-title":"Clin. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"14747","DOI":"10.1074\/jbc.M109.093039","article-title":"Estrogen Inhibits Transforming Growth Factor \u03b2 Signaling by Promoting Smad2\/3 Degradation","volume":"285","author":"Ito","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1074\/jbc.M108855200","article-title":"The Androgen Receptor Represses Transforming Growth Factor-\u03b2 Signaling through Interaction with Smad3","volume":"277","author":"Chipuk","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Kunzmann, S., Ottensmeier, B., Speer, C.P., and Fehrholz, M. (2018). Effect of progesterone on Smad signaling and TGF-\u03b2\/Smad-regulated genes in lung epithelial cells. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0200661"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1089\/jir.2011.0049","article-title":"Role of Cytokines in the Pathogenesis and Suppression of Thyroid Autoimmunity","volume":"31","author":"Ganesh","year":"2011","journal-title":"J. Interferon Cytokine Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s40618-019-01105-7","article-title":"Alemtuzumab-induced thyroid events in multiple sclerosis: A systematic review and meta-analysis","volume":"43","author":"Scappaticcio","year":"2020","journal-title":"J. Endocrinol. Investig."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"5724","DOI":"10.1210\/en.2007-1024","article-title":"The Link between Graves\u2019 Disease and Hashimoto\u2019s Thyroiditis: A Role for Regulatory T Cells","volume":"148","author":"McLachlan","year":"2007","journal-title":"Endocrinology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.4049\/jimmunol.180.3.1903","article-title":"Dual Roles of Immunoregulatory Cytokine TGF-\u03b2 in the Pathogenesis of Autoimmunity-Mediated Organ Damage","volume":"180","author":"Saxena","year":"2008","journal-title":"J. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2174\/18715303113139990001","article-title":"Association of Cytokine Gene Polymorphisms (IL6, IL10, TNF-\u03b1, TGF-\u03b2 and IFN-\u03b3) and Graves\u2019 Disease in Turkish Population","volume":"13","author":"Kutluturk","year":"2013","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1440-1827.2011.02661.x","article-title":"Diagnosis of Hashimoto\u2019s thyroiditis and IgG4-related sclerosing disease","volume":"61","author":"Kakudo","year":"2011","journal-title":"Pathol. Int."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1189\/jlb.68.6.828","article-title":"Characterization of thyroid fibrosis in a murine model of granulomatous experimental autoimmune thyroiditis","volume":"68","author":"Chen","year":"2000","journal-title":"J. Leukoc. Biol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jaut.2009.03.010","article-title":"Naturally-existing CD4+CD25+Foxp3+ regulatory T cells are required for tolerance to experimental autoimmune thyroiditis induced by either exogenous or endogenous autoantigen","volume":"33","author":"Morris","year":"2009","journal-title":"J. Autoimmun."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"6236","DOI":"10.4049\/jimmunol.171.11.6236","article-title":"Mechanisms of spontaneous resolution versus fibrosis in granulomatous experimental autoimmune thyroiditis","volume":"171","author":"Chen","year":"2003","journal-title":"J. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.clim.2013.10.001","article-title":"Th17 cell plays a role in the pathogenesis of Hashimoto\u2019s thyroiditis in patients","volume":"149","author":"Li","year":"2013","journal-title":"Clin. Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.intimp.2015.07.019","article-title":"Arg25Pro (c.915G>C) polymorphism of transforming growth factor \u03b21 gene suggests an association with increased risk for Hashimoto\u2019s thyroiditis","volume":"28","author":"Vural","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1089\/thy.2007.0405","article-title":"Cytokines, Graves\u2019 Disease, and Thyroid-Associated Ophthalmopathy","volume":"18","author":"Gianoukakis","year":"2008","journal-title":"Thyroid"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1089\/thy.2008.0255","article-title":"Evidence for Enhanced Thy-1 (CD90) Expression in Orbital Fibroblasts of Patients with Graves\u2019 Ophthalmopathy","volume":"18","author":"Khoo","year":"2008","journal-title":"Thyroid"},{"key":"ref_47","first-page":"903","article-title":"Effect of Tumor Necrosis Factor-\u03b1, Interferon-\u03b3, and Transforming Growth Factor-\u03b2 on Adipogenesis and Expression of Thyrotropin Receptor in Human Orbital Preadipocyte Fibroblasts","volume":"86","author":"Valyasevi","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1167\/iovs.16-20684","article-title":"Sphingosine-1-Phosphate Mediates Fibrosis in Orbital Fibroblasts in Graves\u2019 Orbitopathy","volume":"58","author":"Ko","year":"2017","journal-title":"Investig. Opthalmol. Vis. Sci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1210\/jc.2017-01349","article-title":"Regulation of Orbital Fibrosis and Adipogenesis by Pathogenic Th17 Cells in Graves Orbitopathy","volume":"102","author":"Fang","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1159\/000242477","article-title":"Positive Feedback Loop between Plasminogen Activator Inhibitor-1 and Transforming Growth Factor-\u03b21 during Renal Fibrosis in Diabetes","volume":"30","author":"Seo","year":"2009","journal-title":"Am. J. Nephrol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3109\/13816810.2010.515648","article-title":"Genetic susceptibility to Graves\u2019 ophthalmopathy: The role of polymorphisms in anti-inflammatory cytokine genes","volume":"31","author":"Khalilzadeh","year":"2010","journal-title":"Ophthalmic Genet."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"318464","DOI":"10.1155\/2013\/318464","article-title":"Changes in Maternal Serum Transforming Growth Factor \u03b2-1 during Pregnancy: A Cross-Sectional Study","volume":"2013","author":"Singh","year":"2013","journal-title":"BioMed Res. Int."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/cen.13843","article-title":"Associations of maternal oestradiol, cortisol, and TGF-\u03b21 plasma concentrations with thyroid autoantibodies during pregnancy and postpartum","volume":"89","author":"Sakkas","year":"2018","journal-title":"Clin. Endocrinol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1677\/joe.0.1760069","article-title":"Transforming growth factor \u03b21 inhibits aldosterone and cortisol production in the human adrenocortical cell line NCI-H295R through inhibition of CYP11B1 and CYP11B2 expression","volume":"176","author":"Liakos","year":"2003","journal-title":"J. Endocrinol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1210\/jc.2002-020990","article-title":"Postpartum Thyroiditis Is Associated with Fluctuations in Transforming Growth Factor-\u03b21 Serum Levels","volume":"88","author":"Olivieri","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1089\/thy.1999.9.675","article-title":"The Thyroid Immunology of the Postpartum Period","volume":"9","author":"Davies","year":"1999","journal-title":"Thyroid"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.3389\/fnins.2019.01107","article-title":"Adoptive Transfer of Regulatory T Cells as a Promising Immunotherapy for the Treatment of Multiple Sclerosis","volume":"13","author":"Duffy","year":"2019","journal-title":"Front. Neurosci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1046\/j.1523-1755.2002.00119.x","article-title":"Low TGF-\u03b21 serum levels are a risk factor for atherosclerosis disease in ESRD patients","volume":"61","author":"Stefoni","year":"2002","journal-title":"Kidney Int."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/jcb.20594","article-title":"Evidence for TGF-\u03b21 and bleomycin intracellular signaling through autocrine regulation of Smad 3 binding to the proximal promoter of theSmad 7 gene","volume":"97","author":"Cutroneo","year":"2006","journal-title":"J. Cell. Biochem."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.bbrc.2006.09.069","article-title":"PPAR\u03b3 agonists prevent TGF\u03b21\/Smad3-signaling in human hepatic stellate cells","volume":"350","author":"Zhao","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Azimi, A. (2016). Pentoxifylline Explores New Horizons in Treatment of Hashimoto Thyroiditis. Biol. Med., 8.","DOI":"10.4172\/0974-8369.1000293"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/bjs.9765","article-title":"Effect of LSKL peptide on thrombospondin 1-mediated transforming growth factor \u03b2 signal activation and liver regeneration after hepatectomy in an experimental model","volume":"102","author":"Kuroki","year":"2015","journal-title":"Br. J. Surg."},{"key":"ref_63","first-page":"4680","article-title":"Expression level and clinical significance of IL-2, IL-6 and TGF-\u03b2 in elderly patients with goiter and hyperthyroidism","volume":"21","author":"Lv","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJMra0905750","article-title":"Graves\u2019 Ophthalmopathy","volume":"362","author":"Bahn","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1089\/pho.2014.3716","article-title":"Effects of Low-Level Laser Therapy on the Serum TGF-\u03b21 Concentrations in Individuals with Autoimmune Thyroiditis","volume":"32","author":"Chavantes","year":"2014","journal-title":"Photomed. Laser Surg."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/BF03348195","article-title":"T4 but not T3 administration is associated with increased recurrence of Graves\u2019 disease after successful medical therapy","volume":"26","author":"Mastorakos","year":"2003","journal-title":"J. Endocrinol. Investig."},{"key":"ref_67","first-page":"E3451","article-title":"Thyroid hormones inhibit TGF-\u03b2 signaling and attenuate fibrotic responses","volume":"113","author":"Orozco","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1167\/iovs.15-18018","article-title":"Celecoxib and Pioglitazone as Potential Therapeutics for Regulating TGF-\u03b2\u2013Induced Hyaluronan in Dysthyroid Myopathy","volume":"57","author":"Cheng","year":"2016","journal-title":"Investig. Opthalmol. Vis. Sci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1016\/j.ajpath.2016.08.017","article-title":"The Aryl Hydrocarbon Receptor and Its Ligands Inhibit Myofibroblast Formation and Activation: Implications for Thyroid Eye Disease","volume":"186","author":"Woeller","year":"2016","journal-title":"Am. J. Pathol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ejmech.2015.01.010","article-title":"Small molecules inhibitors of plasminogen activator inhibitor-1\u2014An overview","volume":"92","author":"Rouch","year":"2015","journal-title":"Eur. J. Med. Chem."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/57\/6\/621\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:14:08Z","timestamp":1760163248000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/57\/6\/621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,14]]},"references-count":70,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["medicina57060621"],"URL":"https:\/\/doi.org\/10.3390\/medicina57060621","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,14]]}}}